UiPath targets $2B ARR milestone in FY27 as AI adoption accelerates, updates long-term margin goal

PATH is trading at $12.38, approximately 84.5% below its ATH of $79.82 and only 24.5% above its all-time low of $9.94, presenting a high-risk asymmetric setup. The $2B ARR FY27 target implies ~30-40% cumulative ARR growth from current ~$1.4-1.5B levels, which is achievable but dependent on AI-augmented automation monetization. Monthly volatility of 12.55% (σ) is extreme for a mid-cap software name, meaning position sizing must be severely constrained. The recent 6-period momentum sequence (11.07→12.38, +11.8%) suggests short-term accumulation pressure but remains well within normal noise bands given σ. RPA moat erosion from Microsoft Power Automate and native AI agents represents a structural headwind that the $2B ARR narrative must overcome. Current enterprise value likely sits near 7-9x forward ARR, which is undemanding only if growth re-accelerates materially above current trajectory. ⚡ DEEP SONNET: Accumulate in tranches between $11.50-$12.00 on any near-term consolidation; hard limit entry below $10.50 if macro softens. Avoid chasing above $13.50 ahead of earnings confirmation. | TP:28% SL:16% | 6-9 months (2 earnings cycles to validate ARR trajectory toward $2B target) | Risk:HIGH — Monthly σ of 12.55% translates to ~43% annualized volatility. All-time low proximity ($9.94) provides a technical floor but also signals ongoing fundamental skepticism. The core risk is AI agent proliferation cannibalizing UiPath's RPA value proposition faster than the company can pivot to AI-native workflows. Competitive pressure from Microsoft (bundled), ServiceNow, and Salesforce creates pricing compression risk on new ARR. FY27 is a 2-year horizon where multiple execution quarters must deliver — each miss resets sentiment sharply given this stock's history. | Sizing:CONSERVATIVE